Spotlight Therapeutics

3953 Point Eden Way
United States

Show articles for this employer

About Spotlight Therapeutics

Spotlight Therapeutics is a venture funded early-stage biotechnology company with a mission to develop a new class of therapeutics by enabling direct in vivo gene editing. Founded by Alex Marson (UCSF), Jacob Corn (UZH), and Patrick Hsu (UC-Berkeley) in December of 2017, Spotlight is building its core technology platform to achieve precise in vivo gene editing in targeted cell populations, expanding CRISPR therapeutic applications and patient access.  

Currently, there are no jobs for this employer on BioSpace.

Browse jobs with BioSpace Featured Employers here.